Bleb Vascularity Change After Subconjunctival Injection Bevacizumab

Clinical trial NCT00815594 · UNKNOWN

Trial details

NCT number: NCT00815594
Sponsor: Capital Medical University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Bleb Vascularity Conjunctival Scarring

Start date: 2008-12-01
Primary completion: 2009-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.